Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
7.74M
-
Number of holders
-
9
-
Total shares
-
284K
-
Shares change
-
+9.66K
-
Total reported value, excl. options
-
$328K
-
Value change
-
+$11.4K
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$1.16
Significant Holders of Kazia Therapeutics Limited - American Depositary Shares (KZIA) as of Q2 2023
8 filings reported holding KZIA - Kazia Therapeutics Limited - American Depositary Shares as of Q2 2023.
Kazia Therapeutics Limited - American Depositary Shares (KZIA) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 284K shares
of 7.74M outstanding shares and own 3.67% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (205K shares), ACADIAN ASSET MANAGEMENT LLC (68.2K shares), RHUMBLINE ADVISERS (7.56K shares), BNP PARIBAS ARBITRAGE, SNC (3.3K shares), NewEdge Advisors, LLC (500 shares), BANK OF AMERICA CORP /DE/ (200 shares), Allworth Financial LP (87 shares), Steward Partners Investment Advisory, LLC (25 shares), AdvisorNet Financial, Inc (5 shares), and Belpointe Asset Management LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.